Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men

Diabetes Research and Clinical Practice

Volumn 91, Issue 1, 2011, Pages 61-66

  Karimi, J ^a   Goodarzi, M T ^b   Tavilani, H ^a   Khodadadi, I ^a   Amiri, I ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Advanced glycation endproducts; Diabetes mellitus; Lipid peroxidation; Spermatozoa; Total antioxidant capacity

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; MALE INFERTILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SEMEN ANALYSIS; SEMINAL PLASMA; SPERM;

ADULT; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFERTILITY, MALE; LIPID PEROXIDATION; LYSINE; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SEMEN; SPERMATOZOA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

EID: 78650545726     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.09.024     Document Type: Article

References (37)

1. Sharma R.K., Pasqualotto F.F., Nelson D.R., Thomas A.J., Agarwal A. The reactive oxygen species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Hum Reprod 1999, 14:2801-2807.
2. Hull M.G., Glazener C.M., Kelly N.J., Conway D.I., Foster P.A., Hinton R.A., et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985, 291:1693-1697.
3. Aitken R.J, Baker M.A. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol 2006, 250:66-69.
4. Yonekura H., Yamamoto Y., Sakurai S., Watanabe T., Yamamoto H. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J Pharmacol Sci 2005, 97:305-311.
5. WHO. Diabetes: fact sheet no. 321; 2009.
6. Lutz W. Fertility rates and future population trends: will Europe's birth rate recover or continue to decline?. Int J Androl 2006, 29:25-33.
7. Sexton W.J., Jarow J.P. Effect of diabetes mellitus upon male reproductive function. Urology 1997, 49:508-513.
8. Ballester J., Munoz M.C., Dominguez J., Rigau T., Guinovart J.J., Rodriguez-Gil J.E. Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J Androl 2004, 25:706-719.
9. Scarano W.R., Messias A.G., Oliva S.U., Klinefelter G.R., Kempinas W.G. Sexual behaviour, sperm quantity and quality after short-term streptozotocin-induced hyperglycaemia in rats. Int J Androl 2006, 29:482-488.
10. Ricci G., Catizone A., Esposito R., Pisanti F.A., Vietri M.T., Galdieri M. Diabetic rat testes: morphological and functional alterations. Andrologia 2009, 41:361-368.
11. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
12. Unoki H., Bujo H., Yamagishi S., Takeuchi M., Imaizumi T., Saito Y. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 2007, 76:236-244.
13. Ramasamy R., Vannucci S.J., Yan S.S., Herold K., Yan S.F., Schmidt A.M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005, 15:16R-28R.
14. Ahmed N Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 2005, 67:3-21.
15. Yamagishi S. Advanced glycation end products (AGEs) and their receptor (RAGE) in health and disease. Curr Pharm Des 2008, 14:939.
16. Lewis S.E., Aitken R.J. DNA damage to spermatozoa has impacts on fertilization and pregnancy. Cell Tissue Res 2005, 322:33-41.
17. Tavilani H., Doosti M., Saeidi H. Malondialdehyde levels in sperm and seminal plasma of asthenozoospermic and its relationship with semen parameters. Clin Chim Acta 2005, 356:199-203.
18. Aitken R.J., Clarkson J.S., Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod 1989, 41:183-197.
19. WHO. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th; 1999.
20. Kalousova M., Skrha J., Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res/Acad Sci Bohemoslovaca 2002, 51:597-604.
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
22. Yagi K. Assay for blood plasma or serum. Meth Enzymol 1984, 105:328-331.
23. Agbaje I.M., Rogers D.A., McVicar C.M., McClure N., Atkinson A.B., Mallidis C., et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod 2007, 22:1871-1877.
24. Mallidis C., Agbaje I., Rogers D., Glenn J., McCullough S., Atkinson A.B., et al. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod 2007, 22:2169-2177.
25. Ahmed N., Thornalley P.J. Advanced glycation endproducts: what is their relevance to diabetic complications?. Diabetes Obes Metab 2007, 9:233-245.
26. Yamagishi S., Ueda S., Matsui T., Nakamura K., Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharm Des 2008, 14:962-968.
27. Ahmed K.A., Muniandy S., Ismail I.S. N(epsilon)-(Carboxymethyl)lysine and coronary atherosclerosis-associated low density lipoprotein abnormalities in type 2 diabetes: current status. J Clin Biochem Nutr 2009, 44:14-27.
28. Boehm B.O., Schilling S., Rosinger S., Lang G.E., Lang G.K., Kientsch-Engel R., et al. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia 2004, 47:1376-1379.
29. Lieuw A.F.M.L, van Hinsbergh V.W., Teerlink T., Barto R., Twisk J., Stehouwer C.D., et al. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 2004, 19:631-636.
30. Wautier M.P., Massin P., Guillausseau P.J., Huijberts M., Levy B., Boulanger E., et al. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab 2003, 29:44-52.
31. Mallidis C., Agbaje I.M., Rogers D.A., Glenn J.V., Pringle R., Atkinson A.B., et al. Advanced glycation end products accumulate in the reproductive tract of men with diabetes. Int J Androl 2009, 32:295-305.
32. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009, 52:2251-2263.
33. Mahfouz R, Sharma R., Sharma D., Sabanegh E., Agarwal A. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil Steril 2009, 91:805-811.
34. Nakamura H., Kimura T., Nakajima A., Shimoya K., Takemura M., Hashimoto K., et al. Detection of oxidative stress in seminal plasma and fractionated sperm from subfertile male patients. Eur J Obstet Gynecol Reprod Biol 2002, 105:155-160.
35. Aitken R.J., Harkiss D., Buckingham D.W. Analysis of lipid peroxidation mechanisms in human spermatozoa. Mol Reprod Dev 1993, 35:302-315.
36. Saleh R.A., Agarwal A., Nelson D.R., Nada E.A., El-Tonsy M.H., Alvarez J.G., et al. Increased sperm nuclear DNA damage in normozoospermic infertile men: a prospective study. Fertil Steril 2002, 78:313-318.
37. Koca Y., Ozdal O.L., Celik M., Unal S., Balaban N. Antioxidant activity of seminal plasma in fertile and infertile men. Arch Androl 2003, 49:355-359.